Ibandronate-01 (Ibandronate 01)
Ibandronate Sodium
Product Images NDC 60505-2795
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 60505-2795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-01.jpg (Image 01)
This appears to be instructions for taking a medication called Bandronate Sodium Tablet 150 mg for osteoporosis. The packet contains a monthly supply and should be taken once a month on a chosen day. There are detailed instructions on how to take the pill and reminders to follow the schedule. The pharmacist's guide is mentioned as well as a contact number. However, there are some errors, and the text is difficult to read in places, making it challenging to understand the complete instructions.*
Instructions1.jpg (Instructions1)
Instructions2.jpg (Instructions2)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
